
First malaria drug for newborns and young infants cleared
A new formulation of Novartis' antimalarial Coartem has become the first medicine to be approved for use in very young children.
Newsletters and Deep Dive digital magazine
A new formulation of Novartis' antimalarial Coartem has become the first medicine to be approved for use in very young children.
Medical groups have sued HHS Secretary Robert F Kennedy Jr for removing healthy children and pregnant women from COVID-19 shot recommendations.
LifeArc and Genetics Alliance UK have issued a call to the government to remove obstacles impeding R&D into rare diseases.
Trump's One Big Beautiful Bill Act is signed into law, and commentators are gauging its impact on healthcare insurance coverage.
The ABPI is worried about investment in medicines and moves that could limit patient and doctor treatment choice in the NHS 10-year plan.
Editor's Picks
Newsletters and Deep Dive
digital magazine